Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-09-24

FDA Approved: DIMETHYL FUMARATE — Original Application (Cipla USA Inc.)

View source ↗

Summary

The FDA approved Cipla USA Inc.'s original application for dimethyl fumarate (generic) for the treatment of relapsing forms of multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dimethyl fumarate (Dimethyl fumarate)

Snippet

ORIG AP for DIMETHYL FUMARATE (DIMETHYL FUMARATE)